Roxithromycin
"Roxithromycin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections.
| Descriptor ID |
D015575
|
| MeSH Number(s) |
D02.540.576.500.992.630
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Roxithromycin".
Below are MeSH descriptors whose meaning is more specific than "Roxithromycin".
This graph shows the total number of publications written about "Roxithromycin" by people in this website by year, and whether "Roxithromycin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Roxithromycin" by people in Profiles.
-
Gl?wka E, Wosicka-Frackowiak H, Hyla K, Stefanowska J, Jastrzebska K, Klapiszewski L, Jesionowski T, Cal K. Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles. Eur J Pharm Biopharm. 2014 Sep; 88(1):75-84.
-
Bunn PA. Editorial comments on 'Reduction of chemotherapy-induced febrile leucopenia by prophylactic use of ciprofloxacin and roxithromycin in small-cell lung cancer patients: an EORTC double-blind placebo-controlled phase III study'. Ann Oncol. 2001 Oct; 12(10):1339-40.